Data as of Oct 22
| -0.14 / -2.81%|
The 7 analysts offering 12-month price forecasts for Novavax Inc have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +106.19% increase from the last price of 4.85.
The current consensus among 7 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.